GlassScriptPhysician profile
Nicholas Quercetti
NPI 1235384561
$32,063.11
in general payments reported to CMS, 2019-2025
23 companies · $5,133 in 2025
The $5,133 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,985 · 2020: $5,721 · 2021: $3,925 · 2022: $4,529 · 2023: $5,220 · 2024: $2,550 · 2025: $5,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,232 · Travel and Lodging: $2,387 · Food and Beverage: $2,334 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,231.98 |
| Travel and Lodging | $2,386.78 |
| Food and Beverage | $2,334.23 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $12,736.25 | 2019-2022 | |
| Synthes Gmbh | $6,429.48 | 2023-2025 | |
| Medical Device Business Services, INC. | $5,918.00 | 2019-2025 | Na |
| Curvafix, INC. | $3,568.53 | 2024-2025 | Curvafix Im Implant |
| Stryker Corporation | $1,641.71 | 2019-2025 | Pro, Accolade, T2 Alpha |
| Depuy Synthes Sales INC. | $921.58 | 2019-2025 | Na, Va-Lcp, Motoband |
| Si-Bone, INC. | $138.04 | 2021-2025 | |
| Radius Health, INC. | $119.75 | 2019-2025 | |
| Integra Lifesciences Corporation | $81.10 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $79.83 | 2019-2024 | Pico 14, Pico, Renasys Go V2 Home |
| Eclipse Technology Solutions INC. | $72.18 | 2023-2025 | |
| Davol INC. | $71.75 | 2021-2023 | |
| Arthrex, INC. | $43.72 | 2024-2025 | |
| Johnson & Johnson Health Care Systems INC. | $43.37 | 2025 | Tfn-Advance |
| Biocomposites INC | $35.94 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $30.19 | 2019 | |
| Treace Medical Concepts, INC. | $27.68 | 2022 | |
| Acera Surgical, INC. | $22.94 | 2024 | Restrata Wound Matrix |
| Bioventus LLC | $20.47 | 2025 | Exogen Ultrasound Bone Healing System |
| Olympus America INC. | $19.33 | 2025 | Soltive |
| Sanara Medtech INC. | $17.64 | 2023 | Celleraterx |
| Globus Medical, INC. | $13.63 | 2024 | Distal Femur Plate System |
| Aap Implants INC | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Quercetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.